Delivery Order SPE2DB22D1202-SPE2DB24FUQE1
Award Date 2/9/24
Potential Completion Date 2/12/24
Potential Value $6.4K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,132.42 firm fixed-price contract is for the delivery of 4567445128 CLINDAMYCIN 900 MG/50 ML-D5W 50ML, with a completion date of March 4, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for providing a range of...
- The U.S. Defense Logistics Agency Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The contract is for the provision of Clindamycin 600mg medication, with a total potential value of $3,398.46 and a period of performance through February 12, 2024. This delivery order is issued under a larger, single-award indefinite delivery contract (IDC) held by...
- The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract worth $1,866.13 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4564109642 - CLINDAMYCIN 900 MG/50 ML-D5W 50ML. This delivery order is part of a larger indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, valued at up to $999,999,999.00 with a performance period through December 31, 2025. The IDC serves as the primary contract...
- The Defense Logistics Agency awarded a $1,989.17 delivery order to AmerisourceBergen Drug Corp for the supply of Clindamycin 900 mg/50 ml in dextrose 5% water solution. This competitively awarded, firm fixed price contract was executed on July 18, 2025, with an ultimate completion date of July 21, 2025, and represents a child delivery order under a larger indefinite delivery contract. The product will be delivered to AmerisourceBergen's corporate headquarters location in Conshohocken,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,478.88 firm fixed-price delivery order is for the supply of CLINDAMYCIN 900 MG/50 ML-D5W 50ML, with a period of performance through November 8, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of a specific pharmaceutical product - Clindamycin 900 mg/50 ml-D5W 50 ml. The contract has a firm fixed price of $3,734.82 and a period of performance through June 13, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $1,561.45 to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Clindamycin 900 mg/50 mL in 5% dextrose solution (50 mL units). This firm fixed price, competitively awarded delivery order is set to be completed by July 31, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $1,354.63 delivery order is for the supply of Clindamycin 900 mg/50 ml-D5W 50 ml, a pharmaceutical product, with a period of performance ending on March 13, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,920.33, is for the supply of Clindamycin 900 mg/50 ml-D5W 50 ml, a prescription antibiotic medication. The contract is a firm-fixed-price delivery order with an ultimate completion date of April 28, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract valued at $1,348.34 to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of 4,564,327,564 units of Clindamycin Phosphate 1% Lotion in 60 mL containers. This order is under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. The IDC...
- SPE2DB22D1202Indefinite Delivery Contract
- SPE2DB22D1202-SPE2DB24FUQE1Delivery Order
The U.S. Defense Logistics Agency has awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $6,389.20 firm fixed price delivery order contract to provide 4563616605 - CLINDAMYCIN 900 MG/50 ML-D5W 50ML. This delivery order is issued under Amerisourcebergen Drug Corp's $999,999,999.00 indefinite delivery contract with DLA Troop Support Medical to deliver pharmaceutical products and medical supplies to military treatment programs and facilities worldwide. The contract has no set-aside designation. Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor on this delivery order, which is scheduled for completion by February 12, 2024.
Generated 5/10/24, 10:03 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.4k | 2/9/24 |